In Monday’s Wall Street session, Ambev S.A. ADR (NYSE:ABEV) shares traded at $2.34, up 1.74% from the previous session.
ABEV stock price is now 20.96% away from the 50-day moving average and 10.74% away from the 200-day moving average. The market capitalization of the company currently stands at $36.80B.
On March 04, 2024, Barclays Downgraded its previous ‘Overweight’ rating to ‘Equal Weight’ on the stock reducing its target price from $3.50 to quote $3, while ‘JP Morgan’ rates the stock as ‘Neutral’
A total of 0.00% of the company’s stock is owned by insiders.
During the past 12 months, Ambev S.A. ADR has had a low of $1.76 and a high of $2.51. As of last week, the company has a debt-to-equity ratio of 0.04, a current ratio of 1.10, and a quick ratio of 0.86. According to the stock market information, the enterprise value for the company is $11356605440, which is based on a 13.88 price-to-earnings ratio, a 1.67 price-to-earnings-growth ratio, and a beta of 0.73. The fifty day moving average price for ABEV is $1.9346 and a two-hundred day moving average price translates $2.14395 for the stock.
The latest earnings results from Ambev S.A. ADR (NYSE: ABEV) was released for 2024-12-31. The net profit margin was 16.11% and return on equity was 16.55% for ABEV. The company reported revenue of $4.67 billion for the quarter, compared to $4.04 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 15.49 percent.
